These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 955746)

  • 21. Immune RNA-mediated transfer of tumor antigen responsiveness to unresponsive peritoneal exudate cells from tumor-bearing animals.
    Braun DP; Dray S
    Cancer Res; 1977 Nov; 37(11):4138-44. PubMed ID: 908048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukocyte adherence inhibition: a simple test for cell-mediated tumour immunity and serum blocking factors.
    Halliday WJ; Miller S
    Int J Cancer; 1972 May; 9(3):477-83. PubMed ID: 4660934
    [No Abstract]   [Full Text] [Related]  

  • 23. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-mediated suppression of tumor immunity has a non-specific component. I. Evidence from transplantation tests.
    Hellström KE; Hellström I
    Int J Cancer; 1981; 27(4):481-5. PubMed ID: 6168591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo inhibition of antitumor immunity by embryonic antigens.
    Lembo R; Parmiani G
    Tumori; 1976; 62(2):211-8. PubMed ID: 1006811
    [No Abstract]   [Full Text] [Related]  

  • 26. Changes in tumor-specific antigen expression during passage in vitro and in vivo of newly derived methylcholanthrene-induced sarcomas of BALB/C mice.
    Law LW
    Int J Cancer; 1980 Feb; 25(2):251-9. PubMed ID: 6156130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Murine Rous-sarcoma-specific immunity detected by leukocyte adherence inhibition: inhibitory effect of normal serum.
    Wikstrand CJ; Proctor JO; Hartsell SC; Haughton G
    Int J Cancer; 1978 May; 21(5):639-47. PubMed ID: 207648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 44-kd oncofetal transplantation antigen in rodent and human fetal cells. Implications of recrudescence in human and rodent cancers.
    Coggin JH; Rohrer SD; Hester RD; Barsoum AL; Rashid HU; Gussack GS
    Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1257-66. PubMed ID: 8217085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens.
    Frbes JT; Nakaw Y; Smith RT
    J Exp Med; 1975 May; 141(5):1181-200. PubMed ID: 47896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serological analysis of cell surface antigens on methylcholanthrene-induced mouse sarcomas with antisera produced against the tumors.
    Tanimoto M; Takahashi T; Nishizuka Y
    Gan; 1982 Apr; 73(2):184-92. PubMed ID: 6288499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of capillary tube leukocyte adherence inhibition for the detection of tumor-specific immune responses.
    Myers WL; O'Keefe ML
    Immunol Commun; 1981; 10(4-5):407-16. PubMed ID: 6174418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro generation of primary and secondary cytotoxic cell-mediated immune responses to chemically induced mouse sarcomas.
    Kall MA; Hellström I; Hellström KE
    Int J Cancer; 1976 Oct; 18(4):488-97. PubMed ID: 977191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro sensitization to embryonic antigens.
    Friend K; Hellström I; Hellström KE
    Int J Cancer; 1976 Dec; 18(6):843-51. PubMed ID: 992911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-reactivity between Bacillus Calmette-Guérin and Rous Virus-induced sarcoma detected in rats by tube leukocyte adherence inhibition assay.
    Holán V; Chutná J; Hasek M
    Cancer Res; 1979 Feb; 39(2 Pt 2):593-6. PubMed ID: 216490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of tumor-associated transplantation antigens of sublines of methylcholanthrene-induced murine tumors passaged separately in vivo for over a decade.
    Hines DL
    Cancer Res; 1986 Oct; 46(10):4921-6. PubMed ID: 3489516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro demonstration of tumor-specific common antigens and embryonal antigens in murine fibrosarcomas induced by 7,12-dimethylbenz(a)anthracene.
    Ménard S; Colnaghi MI; Della Porta G
    Cancer Res; 1973 Mar; 33(3):478-81. PubMed ID: 4689897
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies of lymphocyte stimulation by intact tumor-cell and solubilized tumor antigen.
    Dean JH; McCoy JL; Lewis D; Appella E; Law LW
    Int J Cancer; 1975 Sep; 16(3):465-75. PubMed ID: 51834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbohydrates as antigenic determinants of tumor-associated antigens recognized by monoclonal anti-tumor antibodies produced in a syngeneic system.
    Ito M; Suzuki E; Naiki M; Sendo F; Arai S
    Int J Cancer; 1984 Nov; 34(5):689-97. PubMed ID: 6209227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-specific immunity in 3-methylcholanthrene-induced murine fibrosarcomas. I. In vivo demonstration of immunity with three preparations of soluble antigens.
    Brannen GE; Adams JS; Santos GW
    J Natl Cancer Inst; 1974 Jul; 53(1):165-75. PubMed ID: 4600504
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of syngeneic tumor growth in rats immunized with allogeneic skin grafts.
    Hosokawa M; Imamura M; Oikawa T; Nakayama M; Gotohda E; Sendo F; Kodama T; Kobayashi H
    Int J Cancer; 1976 Sep; 18(3):369-74. PubMed ID: 783054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.